1. Home
  2. Labeler Index
  3. Novartis Pharmaceuticals Corporation
  4. 0078-0490
  5. Product Images: Exforge

Product Images Exforge

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - exforge 01
  2. Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - exforge 02
  3. Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - exforge 03
  4. Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - exforge 04
  5. Amlodipine besylate structural formula - exforge 05
  6. Valsartan structural formula - exforge 06
  7. PRINCIPAL DISPLAY PANEL NDC 0078-0488-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/160 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 07
  8. PRINCIPAL DISPLAY PANEL NDC 0078-0489-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/160 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 08
  9. PRINCIPAL DISPLAY PANEL NDC 0078-0490-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/320 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 09
  10. PRINCIPAL DISPLAY PANEL NDC 0078-0491-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/320 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 10

Product Label Images

The following 10 images provide visual information about the product associated with Exforge NDC 0078-0490 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - exforge 01

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - exforge 01

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - exforge 02

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - exforge 02

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - exforge 03

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - exforge 03

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - exforge 04

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - exforge 04

Amlodipine besylate structural formula - exforge 05

Amlodipine besylate structural formula - exforge 05

Valsartan structural formula - exforge 06

Valsartan structural formula - exforge 06

PRINCIPAL DISPLAY PANEL NDC 0078-0488-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/160 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 07

PRINCIPAL DISPLAY PANEL NDC 0078-0488-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/160 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 07

This is a medication with the name "Exforge" which has the National Drug Code (NDC) of 0078:0488-15. It consists of 2 active ingredients, Amlodpine and Valsartan. The dosage strength of this medication is 6mg/160mg (amlodpine/valsartan) and comes in a pack of 30 tablets, which requires a prescription to be dispensed. The manufacturer of this drug is Novartis. The remaining text is not readable.*

PRINCIPAL DISPLAY PANEL NDC 0078-0489-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/160 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 08

PRINCIPAL DISPLAY PANEL NDC 0078-0489-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/160 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 08

This is a description of a medication called EXFORGE. It comes in the form of tablets with a dosage of 10mg/160mg and is available in a bottle of 30 tablets. The manufacturer of this medication is Novartis. The NDC (National Drug Code) number assigned to this medication is 0074048915. No further details are available from the provided text.*

PRINCIPAL DISPLAY PANEL NDC 0078-0490-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/320 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 09

PRINCIPAL DISPLAY PANEL NDC 0078-0490-15 EXFORGE® (amlodipine and valsartan) Tablets 5 mg*/320 mg *each tablet contains 6.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 09

PRINCIPAL DISPLAY PANEL NDC 0078-0491-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/320 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 10

PRINCIPAL DISPLAY PANEL NDC 0078-0491-15 EXFORGE® (amlodipine and valsartan) Tablets 10 mg*/320 mg *each tablet contains 13.9 mg of amlodipine besylate 30 tablets Rx only NOVARTIS - exforge 10

This appears to be a medical document for a prescription drug called "amlodipine and valsartan." The drug is contained in tablets that are 10mg/320mg each and there are 30 of them per container. The text also includes a product code and an NDC number but no further information is available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.